Please login to the form below
Vaccine
This page shows the latest Vaccine news and features for those working in and with pharma, biotech and healthcare.
Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
COVID-19 vaccines, subject to authorisation from the US Food and Drug Administration (FDA). ... Vaccines have been and will remain critical to protecting people of all ages against COVID-19.
Latest news
-
EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
RSV, Bavarian Nordic’s vaccine candidate, to address the unmet medical need in the proposed target population. ... The incorporation of five antigens sets MVA-BN RSV apart from other RSV vaccine candidates currently in development.
-
Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
Preliminary laboratory studies show both vaccines neutralise Omicron BA.4 and BA.5. ... The data shows that a booster dose of both Omicron-adapted vaccines gave a considerably higher immune response against Omicron BA.1, compared to Pfizer/BioNTech’s
-
Sanofi and GSK report positive data for COVID-19 Beta vaccine
The VAT08 vaccine trial assessed an adjuvant bivalent D614 and Beta (B.1.351) vaccine. ... Speaking on behalf of GSK, Roger Connor, president of GSK vaccines, said: “The positive data shows efficacy of our protein-based, bivalent adjuvanted vaccine
-
Pfizer donates $5m in Russian profits to humanitarian causes amid war in Ukraine
economic sanctions and an obligation to deliver life-saving vaccines and medicines regardless of circumstances.
-
Moderna to launch Innovation and Technology Center in the UK
Moderna, a biotech company specialising in messenger RNA (mRNA) therapeutics and vaccines, and the UK government have reached an agreement in principle for an mRNA Innovation and Technology Center in the ... The company, with the support of the UK
More from news
Approximately 235 fully matching, plus 1,511 partially matching documents found.
Latest Intelligence
-
The pharma dichotomy
While other sectors were plunged into chaos, COVID-19 highlighted our industry’s remarkable capacity for innovation, with new vaccines and treatments being developed, tested and approved in record time.
-
A creative awakening – how pharma is bringing innovation to the patient journey
The speed with which systems changed to cope with COVID-19 and the solutions that emerged, over and above the vaccines, demonstrated how agile the industry is.
-
Expanding clinical trial access: a global imperative requiring local focus
In our most recent work in COVID-19 vaccine and treatment trials, there were several key ways that intentional a priori design and execution helped broaden participation among underserved populations that ... key. In our work on US-based COVID-19 vaccine
-
Impact That Matters
During the pandemic, we have accelerated recruitment for COVID-19 trials to explore new treatment options for those that can’t be helped by the vaccines.
-
Public is more comfortable with health data sharing if they know it is to support breakthrough treatments and vaccines
It has accelerated and improved understanding of the virus, the development and assessment of vaccines, treatments and public health strategies. ... Similarly, those willing to share their data with pharmaceutical companies jumps from 23% to 60% if used
More from intelligence
Approximately 6 fully matching, plus 138 partially matching documents found.
Latest appointments
-
ENGINE MHP+Mischief bolsters healthcare comms expertise with new senior hires
In this role, he oversaw all media relations for the UK’s COVID-19 vaccination programme, providing strategic advice to Vaccines Minister Nadhim Zahawi and Health and Social Care Secretary Matt
-
Virtual agency The Difference Collective makes new hires to senior team
Hornby has led communications for the UK government’s Vaccine Taskforce and previously led media and communications for GlaxoSmithKline.
-
Merck’s R&D chief Roger Perlmutter heads for the exit as Dean Li takes the helm
Over the course of his most recent stint at Merck, the company has achieved over 100 regulatory approvals for its medicines and vaccines globally. ... As a result of Roger’s hands-on and inspirational leadership, MRL is well positioned to bring forward
-
Evoke KYNE promotes Dante DelVecchio to senior VP
In his new role, he will become a member of the firm’s senior management team, and will continue to oversee key client engagements in infectious diseases, vaccines and immuno-oncology.
-
New hires at Bayer, Eisai and Accord Healthcare
Most recently, she held the position of vice president of M&A operations and divestitures and led the infectious diseases and vaccines business development. ... She joins Eisai from Merck, where she served as executive director, clinical quality assurance
More from appointments
Approximately 5 fully matching, plus 66 partially matching documents found.
Latest from PMHub
-
Could femtech be the answer to the gender health gap?
25. 5. It's bridging the gender data gap. As we mentioned in our recent blog ‘Why the COVID-19 vaccines are a women’s health issue’, there is a concerning
-
Reflections on the MAPS EMEA 2022 Annual Meeting
BioNTech’s Project Lightspeed is a case study in this – setting the highest standard to accelerate the development and commercialization of a COVID-19 vaccine in record time.
-
What does the future hold for clinical trial recruitment?
This work is ongoing as the virus mutates; last month, it was announced that Pfizer and BioNTech had started clinical trials for a new Covid vaccine targeting the Omicron variant. ... While Covid-19 vaccine trials have garnered headlines these have
-
How scientific storytelling can help Pharma cut through the noise
This again can be particularly powerful for comparisons of risk – such as the risk of adverse side effects from Covid-19 vaccines.
-
MS Awareness Week - Matt's story
I got a sort of full check-up and she made sure I had all my vaccines and sent me for my eyes checking and stuff.
More from PMHub
Approximately 16 fully matching, plus 99 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- FDA issues innovative proposal to increase nonprescription drug access
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NHS App to revolutionise digital health and care with major digital updates by 2023
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
- Realising the potential of omnichannel in medical communications
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- AI is transforming pharma R&D – now it can transform pharma marketing
- J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma
- Six UK universities receive grant for research into motor neurone disease
- My journey advancing the science in pulmonary hypertension
PMHub
Blue Latitude Health
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
